84 related articles for article (PubMed ID: 21046227)
1. Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk.
Yang R; Dick M; Marme F; Schneeweiss A; Langheinz A; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Varon R; Schott S; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Müller H; Arndt V; Brenner H; Sohn C; Burwinkel B
Breast Cancer Res Treat; 2011 Jun; 127(2):549-54. PubMed ID: 21046227
[TBL] [Abstract][Full Text] [Related]
2. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk.
Yang R; Schlehe B; Hemminki K; Sutter C; Bugert P; Wappenschmidt B; Volkmann J; Varon R; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2010 Jun; 121(3):693-702. PubMed ID: 19921425
[TBL] [Abstract][Full Text] [Related]
3. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
[TBL] [Abstract][Full Text] [Related]
4. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
5. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients.
Pastrello C; Polesel J; Della Puppa L; Viel A; Maestro R
Carcinogenesis; 2010 Dec; 31(12):2124-6. PubMed ID: 20810544
[TBL] [Abstract][Full Text] [Related]
6. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
[TBL] [Abstract][Full Text] [Related]
7. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population.
Srivastava K; Srivastava A; Mittal B
J Hum Genet; 2010 Aug; 55(8):495-9. PubMed ID: 20520619
[TBL] [Abstract][Full Text] [Related]
8. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
[TBL] [Abstract][Full Text] [Related]
10. A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women.
Tchatchou S; Jung A; Hemminki K; Sutter C; Wappenschmidt B; Bugert P; Weber BH; Niederacher D; Arnold N; Varon-Mateeva R; Ditsch N; Meindl A; Schmutzler RK; Bartram CR; Burwinkel B
Carcinogenesis; 2009 Jan; 30(1):59-64. PubMed ID: 19028706
[TBL] [Abstract][Full Text] [Related]
11. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
12. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
13. A genetic variant located in miR-423 is associated with reduced breast cancer risk.
Smith RA; Jedlinski DJ; Gabrovska PN; Weinstein SR; Haupt L; Griffiths LR
Cancer Genomics Proteomics; 2012; 9(3):115-8. PubMed ID: 22593246
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker.
Brendle A; Lei H; Brandt A; Johansson R; Enquist K; Henriksson R; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jul; 29(7):1394-9. PubMed ID: 18550570
[TBL] [Abstract][Full Text] [Related]
15. Germline mutation of microRNA-125a is associated with breast cancer.
Li W; Duan R; Kooy F; Sherman SL; Zhou W; Jin P
J Med Genet; 2009 May; 46(5):358-60. PubMed ID: 19411564
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
17. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
[TBL] [Abstract][Full Text] [Related]
18. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma.
Zhou B; Wang K; Wang Y; Xi M; Zhang Z; Song Y; Zhang L
Mol Carcinog; 2011 Jul; 50(7):499-505. PubMed ID: 21319225
[TBL] [Abstract][Full Text] [Related]
19. ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Nordgard SH; Ritchie MD; Jensrud SD; Motsinger AA; Alnaes GI; Lemmon G; Berg M; Geisler S; Moore JH; Lønning PE; Børresen-Dale AL; Kristensen VN
Pharmacogenet Genomics; 2007 Feb; 17(2):127-36. PubMed ID: 17301692
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in epigenetic genes and breast cancer risk.
Cebrian A; Pharoah PD; Ahmed S; Ropero S; Fraga MF; Smith PL; Conroy D; Luben R; Perkins B; Easton DF; Dunning AM; Esteller M; Ponder BA
Carcinogenesis; 2006 Aug; 27(8):1661-9. PubMed ID: 16501248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
